rs145205388
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_002469.3(MYF6):c.528T>C(p.Gly176Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000982 in 1,454,918 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00068 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 6 hom. )
Consequence
MYF6
NM_002469.3 synonymous
NM_002469.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.840
Publications
1 publications found
Genes affected
MYF6 (HGNC:7566): (myogenic factor 6) The protein encoded by this gene is a probable basic helix-loop-helix (bHLH) DNA binding protein involved in muscle differentiation. The encoded protein likely acts as a heterodimer with another bHLH protein. Defects in this gene are a cause of autosomal dominant centronuclear myopathy (ADCNM). [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 12-80708532-T-C is Benign according to our data. Variant chr12-80708532-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 435911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.84 with no splicing effect.
BS2
High AC in GnomAd4 at 96 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000676 AC: 96AN: 141964Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
96
AN:
141964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000966 AC: 243AN: 251446 AF XY: 0.000993 show subpopulations
GnomAD2 exomes
AF:
AC:
243
AN:
251446
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00102 AC: 1333AN: 1312850Hom.: 6 Cov.: 33 AF XY: 0.00105 AC XY: 684AN XY: 652286 show subpopulations
GnomAD4 exome
AF:
AC:
1333
AN:
1312850
Hom.:
Cov.:
33
AF XY:
AC XY:
684
AN XY:
652286
show subpopulations
African (AFR)
AF:
AC:
14
AN:
28976
American (AMR)
AF:
AC:
39
AN:
40202
Ashkenazi Jewish (ASJ)
AF:
AC:
93
AN:
20524
East Asian (EAS)
AF:
AC:
0
AN:
26114
South Asian (SAS)
AF:
AC:
58
AN:
84988
European-Finnish (FIN)
AF:
AC:
16
AN:
38914
Middle Eastern (MID)
AF:
AC:
62
AN:
5008
European-Non Finnish (NFE)
AF:
AC:
964
AN:
1017882
Other (OTH)
AF:
AC:
87
AN:
50242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
70
140
211
281
351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000676 AC: 96AN: 142068Hom.: 0 Cov.: 32 AF XY: 0.000536 AC XY: 37AN XY: 69000 show subpopulations
GnomAD4 genome
AF:
AC:
96
AN:
142068
Hom.:
Cov.:
32
AF XY:
AC XY:
37
AN XY:
69000
show subpopulations
African (AFR)
AF:
AC:
7
AN:
38666
American (AMR)
AF:
AC:
15
AN:
14268
Ashkenazi Jewish (ASJ)
AF:
AC:
9
AN:
3372
East Asian (EAS)
AF:
AC:
0
AN:
4140
South Asian (SAS)
AF:
AC:
1
AN:
3934
European-Finnish (FIN)
AF:
AC:
1
AN:
9102
Middle Eastern (MID)
AF:
AC:
3
AN:
286
European-Non Finnish (NFE)
AF:
AC:
58
AN:
65416
Other (OTH)
AF:
AC:
2
AN:
2000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
MYF6: BP4, BP7 -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
Jul 21, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal dominant centronuclear myopathy Benign:1
Dec 06, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.